Adaptive Biotechnologies Corporation Common Stock Share Price
NASDAQ: ADPTHealthcare
Live Adaptive Biotechnologies Corporation Common Stock Share Price Chart
O H L
Adaptive Biotechnologies Corporation Common Stock Performance Overview
Days Range
▼
$28.03Low
$28.44High
Markets Today
| Previous Close | $28.55 |
|---|---|
| Open | $28.44 |
| Volume | 205,450 |
| Day's Range | $28.03 - $28.44 |
| 52W Range | $12.00 - $28.72 |
| Market Cap | $4.42 B |
Historical Performance
| 1M Returns | +16.25 |
|---|---|
| 3M Returns | +62.86 |
| 6M Returns | +114.98 |
| 1Y Returns | +107.33 |
| 5Y Returns | -28.18 |
| 10Y Returns | -30.14 |
Adaptive Biotechnologies Corporation Common Stock Fundamentals
| Market Cap | $4.42 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $276.98 M |
| ROE TTM | -0.28 |
| EPS TTM | $-0.41 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 30.80 |
| EBITDA | $-39.29 M |
| Profit Margin | -21.48 |
| Market Cap | $4.42 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $276.98 M |
| ROE TTM | -0.28 |
| EPS TTM | $-0.41 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 30.80 |
| EBITDA | $-39.29 M |
| Profit Margin | -21.48 |
Adaptive Biotechnologies Corporation Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $52.44 M | $58.88 M | $93.97 M | $71.68 M | $70.87 M | $71.55 M |
| Gross Profit + | $35.46 M | $40.88 M | $75.82 M | $53.46 M | $52.17 M | $51.39 M |
| Operating Income | -$29.60 M | -$25.04 M | $10.29 M | -$12.77 M | -$19.21 M | -$15.77 M |
| EBITDA | -$24.87 M | -$20.53 M | $14.70 M | -$8.58 M | -$15.37 M | -$12.07 M |
| Interest Expense | -$2.90 M | -$2.95 M | -$2.97 M | -$2.95 M | -$2.89 M | -$2.69 M |
| Depreciation | $4.73 M | $4.50 M | $4.41 M | $4.20 M | $3.84 M | $3.69 M |
| Income Before Tax | -$29.83 M | -$25.59 M | $9.54 M | -$13.58 M | -$20.02 M | -$39.94 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$29.83 M | -$25.59 M | $9.54 M | -$13.58 M | -$20.02 M | -$39.94 M |
| Net Profit Margin | -56.88% | -43.47% | 10.16% | -18.94% | -28.24% | -55.82% |
Adaptive Biotechnologies Corporation Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $15.00 K | $15.00 K | $15.00 K | $15.00 K | $16.00 K | $16.00 K |
| Reserve & Surplus | -$1.33 B | -$1.36 B | -$1.35 B | -$1.36 B | -$1.38 B | -$1.42 B |
| Non-Current Liabilities | $232.82 M | $224.96 M | $203.00 M | $197.82 M | $194.69 M | $402.30 M |
| Current Liabilities | $87.81 M | $92.14 M | $83.36 M | $89.92 M | $87.01 M | $87.71 M |
| Total Liabilities | $320.63 M | $317.10 M | $286.36 M | $287.74 M | $281.70 M | $490.02 M |
| Fixed Assets | $47.44 M | $43.64 M | $39.65 M | $35.83 M | $32.08 M | $30.34 M |
| Current Assets | $256.49 M | $261.86 M | $281.44 M | $300.19 M | $291.81 M | $420.56 M |
| Total Assets | $510.85 M | $496.64 M | $490.61 M | $512.74 M | $505.94 M | $640.68 M |
Adaptive Biotechnologies Corporation Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$29.83 M | -$25.59 M | $9.54 M | -$13.58 M | -$20.02 M | -$39.94 M |
| Operating Cash Flow | -$28.48 M | -$12.43 M | -$7.13 M | $2.06 M | -$9.54 M | -$6.40 M |
| Investing Cash Flow | $25.57 M | $3.35 M | $17.28 M | -$8.25 M | $9.14 M | -$43.48 M |
| Financing Cash Flow | $5.45 M | $1.61 M | $1.68 M | $21.66 M | $7.50 M | $142.19 M |
| Change in Cash | $2.54 M | -$7.47 M | $11.84 M | $15.46 M | $7.11 M | $92.31 M |
Adaptive Biotechnologies Corporation Common Stock Return Calculator
The Adaptive Biotechnologies Corporation Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$7,031
Invested Amount$10,000
Est. Returns$-2,969
About Adaptive Biotechnologies Corporation Common Stock
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.
Popular Stocks
FAQs
What is the share price of Adaptive Biotechnologies Corporation Common Stock today?
Adaptive Biotechnologies Corporation Common Stock (ADPT) share price as of September 18, 2026 is $27.95. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Adaptive Biotechnologies Corporation Common Stock?
Yes, Indian Investors can invest in the Adaptive Biotechnologies Corporation Common Stock (ADPT) Share by opening an international trading account with Angel One.
How can I purchase Adaptive Biotechnologies Corporation Common Stock shares in India?
Purchasing Adaptive Biotechnologies Corporation Common Stock (ADPT) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Adaptive Biotechnologies Corporation Common Stock (ADPT) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Adaptive Biotechnologies Corporation Common Stock?
Yes, you can purchase fractional shares of Adaptive Biotechnologies Corporation Common Stock (ADPT) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Adaptive Biotechnologies Corporation Common Stock?
The market capitalization of Adaptive Biotechnologies Corporation Common Stock on September 18, 2026, is $4.42 B.
In which sector Adaptive Biotechnologies Corporation Common Stock belongs?
Adaptive Biotechnologies Corporation Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Adaptive Biotechnologies Corporation Common Stock stocks?
In order to invest in Adaptive Biotechnologies Corporation Common Stock (ADPT) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
